4-(1,3-dimethyl-2,6-dioxo-8-propoxy-2,3,6,7-tetrahydro-1H-purin-7-yl)-N-[4-(propan-2-yl)phenyl]butanamide

ID: ALA4291934

PubChem CID: 145986925

Max Phase: Preclinical

Molecular Formula: C23H31N5O4

Molecular Weight: 441.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOc1nc2c(c(=O)n(C)c(=O)n2C)n1CCCC(=O)Nc1ccc(C(C)C)cc1

Standard InChI:  InChI=1S/C23H31N5O4/c1-6-14-32-22-25-20-19(21(30)27(5)23(31)26(20)4)28(22)13-7-8-18(29)24-17-11-9-16(10-12-17)15(2)3/h9-12,15H,6-8,13-14H2,1-5H3,(H,24,29)

Standard InChI Key:  UNHDMYZCRLZPEZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   18.1228  -21.8814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6110  -21.2259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1359  -20.5579    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3481  -21.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3597  -20.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6621  -20.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9484  -20.7845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9367  -21.6012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6388  -22.0220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6282  -22.8391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2472  -20.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6749  -19.5714    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2228  -21.9989    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4282  -21.2349    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8290  -21.9470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3948  -19.7828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1955  -19.6195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4544  -18.8444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2551  -18.6810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5139  -17.9060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7969  -19.2928    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3146  -17.7426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8514  -18.3552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6514  -18.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9110  -17.4166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3644  -16.8034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5664  -16.9694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6461  -21.9560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7115  -17.2522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2541  -17.8632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9693  -16.4768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0469  -22.6681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  1  2  2  0
  2  3  1  0
  3  5  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  0
  6 12  2  0
  8 13  2  0
  2 14  1  0
 14 15  1  0
  3 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 15 28  1  0
 25 29  1  0
 29 30  1  0
 29 31  1  0
 28 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4291934

    ---

Associated Targets(Human)

PDE7A Tclin Phosphodiesterase 7A (1104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4B Tclin Phosphodiesterase 4B (2748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRPA1 Tclin Transient receptor potential cation channel subfamily A member 1 (1847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 441.53Molecular Weight (Monoisotopic): 441.2376AlogP: 2.76#Rotatable Bonds: 9
Polar Surface Area: 100.15Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -1.42

References

1. Chłoń-Rzepa G, Ślusarczyk M, Jankowska A, Gawalska A, Bucki A, Kołaczkowski M, Świerczek A, Pociecha K, Wyska E, Zygmunt M, Kazek G, Sałat K, Pawłowski M..  (2018)  Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.,  158  [PMID:30245393] [10.1016/j.ejmech.2018.09.021]
2. Dąbrowska M, Starek M, Chłoń-Rzepa G, Zagórska A, Komsta Ł, Jankowska A, Ślusarczyk M, Pawłowski M..  (2021)  Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity.,  49  [PMID:34391892] [10.1016/j.bmcl.2021.128318]

Source